Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robbins, M. S.
Right arrow Articles by Elde, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robbins, M. S.
Right arrow Articles by Elde, R. P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 30, Issue 2 168-171, Copyright © 1981 by American Diabetes Association


ARTICLES

Effect of muscimol on glucose-stimulated somatostatin and insulin release from the isolated, perfused rat pancreas

MS Robbins, LH Grouse, RL Sorenson and RP Elde

This study examines the effect of muscimol, a high affinity, specific gamma-aminobutyric acid (GABA) agonist, on glucose-stimulated somatostatin and insulin release from the isolated, perfused rat pancreas. Perfusion with low glucose (50 mg/dl) conditions resulted in basal somatostatin release of 46 +/- 4 pg/ml. Basal insulin release was less than 20 microU/ml. High glucose (300 mg/dl) conditions stimulated somatostatin and insulin release. Steady-state levels of somatostatin and insulin release under high glucose conditions were 425 +/- 12 pg/ml and 419 +/- 18 microU/ml, respectively. Perfusion with medium containing 1 microM muscimol inhibited glucose-stimulated somatostatin release by 38%, whereas the course of glucose-stimulated insulin release was unaffected. Tentative conclusions from this study are (1) that GABA is potentially a modulator of islet somatostatin but not insulin release, and (2) the fact that somatostatin, an inhibitor of insulin, can be suppressed 38% without coincidental increase in insulin release seems to indicate that, under high glucose conditions, somatostatin is without a significant paracrine effect on the beta-cells.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos
GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Uehara, A. Muroyama, N. Echigo, R. Morimoto, M. Otsuka, S. Yatsushiro, and Y. Moriyama
Metabotropic Glutamate Receptor Type 4 Is Involved in Autoinhibitory Cascade for Glucagon Secretion by {alpha}-Cells of Islet of Langerhans
Diabetes, April 1, 2004; 53(4): 998 - 1006.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
M. Braun, A. Wendt, B. Birnir, J. Broman, L. Eliasson, J. Galvanovskis, J. Gromada, H. Mulder, and P. Rorsman
Regulated Exocytosis of GABA-containing Synaptic-like Microvesicles in Pancreatic {beta}-cells
J. Gen. Physiol., February 23, 2004; 123(3): 191 - 204.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
I. K. Franklin and C. B. Wollheim
GABA in the Endocrine Pancreas: Its Putative Role as an Islet Cell Paracrine-signalling Molecule
J. Gen. Physiol., February 23, 2004; 123(3): 185 - 190.
[Full Text] [PDF]


Home page
DiabetesHome page
M. Hayashi, M. Otsuka, R. Morimoto, A. Muroyama, S. Uehara, A. Yamamoto, and Y. Moriyama
Vesicular Inhibitory Amino Acid Transporter Is Present in Glucagon-Containing Secretory Granules in {alpha}TC6 Cells, Mouse Clonal {alpha}-Cells, and {alpha}-Cells of Islets of Langerhans
Diabetes, August 1, 2003; 52(8): 2066 - 2074.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hayashi, H. Yamada, S. Uehara, R. Morimoto, A. Muroyama, S. Yatsushiro, J. Takeda, A. Yamamoto, and Y. Moriyama
Secretory Granule-mediated Co-secretion of L-Glutamate and Glucagon Triggers Glutamatergic Signal Transmission in Islets of Langerhans
J. Biol. Chem., January 10, 2003; 278(3): 1966 - 1974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. S. Park and H. J. Park
Effects of gamma -aminobutyric acid on secretagogue-induced exocrine secretion of isolated, perfused rat pancreas
Am J Physiol Gastrointest Liver Physiol, October 1, 2000; 279(4): G677 - G682.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Shi, J. Kanaani, V. Menard-Rose, Y. H. Ma, P.-Y. Chang, D. Hanahan, A. Tobin, G. Grodsky, and S. Baekkeskov
Increased expression of GAD65 and GABA in pancreatic beta -cells impairs first-phase insulin secretion
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E684 - E694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1981 by the American Diabetes Association.